Cardiff Oncology Is A Clinical Stage Biotechnology Company Based In San Diegocaliforniaformerly Known As Trovagenethe Company Rebranded In 2020Cardiff Oncology Specializes In Developing Precision Oncology Therapiesfocusing On Inhibiting Polo Like Kinase 1Plk1 A Key Target In Cancer Treatment The Company S Lead Product Candidateonvansertibis A Plk1 Inhibitor Currently Being Evaluated In Various Clinical Programsthese Include Trials For Ras Mutated Metastatic Colorectal Cancermetastatic Pancreatic Ductal Adenocarcinomasmall Cell Lung Cancerand Triple Negative Breast Cancercardiff Oncology Collaborates With Leading Healthcare Institutionssuch As Memorial Sloan Kettering Cancer Centerto Advance Its Clinical Trials And Address Significant Unmet Medical Needs In Cancer Care
